In preprint
Jani C, Marsh A, Uchil P, Jain N, Baskir ZR, Glover OT, Root DE, Doench JG, Barczak AK. Vps18 contributes to phagosome membrane integrity in Mycobacterium tuberculosis-infected macrophages. Biorxiv. doi:https://doi.org/10.1101/2023.10.01.560397
Hartmann JA, Marcella R. Cardoso, Ramiro Talarico MC, Kenney DJ, Turcinovic J, O’Connell AK, Gertje HP, Marino C, Ojeda PE, De Paula EV, Orsi FA, Velloso LA, Ploss A, Hoelzemer A, Carrington M, Barczak AK, Crossland NA, Douam F, Boucau J*, Garcia-Beltran WF*. Evasion of NKG2D-Mediated Cytotoxic Immunity by Sarbecoviruses. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4549874 *contributed equally
2024
Li Y, Choudhary MC, Regan J, Boucau J, Nathan A, Speidel T, Liew MY, Edelstein GE, Kawano Y, Uddin R, Deo R, Marino C, Getz MA, Reynold Z , Barry M, Gilbert RF, Tien D, Sagar S, Vyas TD, Flynn JP,Hammond SP , Novack LA, Choi B, Cernadas M, Wallace ZS, Sparks JA, Vyas JM, Seaman MS , Gaiha GD,Siedner MJ* , Barczak AK*, Lemieux JE*, Li JZ*. SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency. Sci Transl Med. 2024 Jan 24;16(731):eadk1599. *contributed equally
2023
Edelstein GE, Boucau J, Uddin R, Marino C, Liew MY, Barry M, Choudhary MC, Gilbert RF, Reynolds Z, Li Y, Tien D, Sagar S, Vyas TD, Kawano Y, Sparks JA, Hammond SP, Wallace Z, Vyas JM, Barczak AK*, Lemieux JE*, Li JZ*, Siedner MJ*. SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy. Ann Intern Med. 2023 Dec;176(12):1577-1585.
*contributed equally
Jani C, Solomon SL, Peters JM, Pringle SC, Hinman AE, Boucau J, Bryson BD, Barczak AK. TLR2 is non-redundant in the population and subpopulation responses to Mycobacterium tuberculosis in macrophages and in vivo. mSystems 2023, Jul 13; e0005223. doi: 10.1128/msystems.00052-23.
McNamara R, Maron J, Boucau J, Roy V, Webb N, Bertera H, The Positives Study Staff, Barczak AK, Franko N, Logue N, Kemp M, Li J, Zhou L, Hsieh C-L, McLellan J, Siedner M, Seaman M, Lemieux J, Chu H, Alter G. Anamnestic Humoral Correlates of Immunity Across SARS-CoV-2 Variants of Concern. mBio. 2023 Aug 3:e0090223. doi: 10.1128/mbio.00902-23
Edelstein GE, Boucau J, Uddin R, Marino C, Liew MY, Barry M, Choudhary MC, Gilbert RF, Reynolds Z, Li Y, Tien D, Sagar S, Vyas TD, Kawano Y, Sparks JA, Hammond SP, Wallace Z, Vyas JM, Barczak AK*, Lemieux JE*, Li JZ*, Siedner MJ*. SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy. Annals of Internal Medicine, in press.
*contributed equally
2022
Jani C, Barczak AK. Tag you're it: A phosphatase inhibitor changes the fate of intracellular mycobacteria. Cell Chem Biol. 2022 Jul 21;29(7):1065-1067. doi: 10.1016/j.chembiol.2022.06.008. PMID: 35868234
Seaman MS, Siedner MJ, Boucau J, Lavine CL, Ghantous F, Liew MY, Mathews JI, Singh A, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Lipiner T, Kittilson A, Melberg M, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Goldberg MB, Luban J, Li JZ, Barczak AK, Lemieux JE Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant.. JCI Insight. 2022 Oct 10;7(19):e159944. doi: 10.1172/jci.insight.159944. PMID: 36214224 Free PMC article.
Boucau J, Chew KW, Choudhary MC, Deo R, Regan J, Flynn JP, Crain CR, Hughes MD, Ritz J, Moser C, Dragavon JA, Javan AC, Nirula A, Klekotka P, Greninger AL, Coombs RW, Fischer WA 2nd, Daar ES, Wohl DA, Eron JJ, Currier JS, Smith DM; POSITIVES study team, Li JZ*, Barczak AK*; ACTIV-2/A5401 Study Team. Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection. Cell Rep Med. 2022 Jun 20:100678. doi: 10.1016/j.xcrm.2022.100678. Epub ahead of print. PMID: 35793677. *contributed equally
Boucau J, Marino C, Regan J, Uddin R, Choudhary MC, Flynn JP, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Lipiner T, Kittilson A, Melberg M, Li Y, Gilbert RF, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Goldberg MB, Vyas JM, Li JZ*, Lemieux JE* , Siedner MJ*, Barczak AK*. Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection. N Engl J Med. 2022 Jun 29. doi: 10.1056/NEJMc2202092. Epub ahead of print. PMID: 35767428. *contributed equally
Boucau J, Uddin R, Marino C, Regan J, Flynn JP, Choudhary MC, Chen G, Stuckwisch AM, Mathews J, Liew MY, Singh A, Reynolds Z, Iyer SL, Chamberlin GC, Vyas TD, Vyas JM, Turbett SE, Li JZ*, Lemieux JE*, Barczak AK*, Siedner MJ*. Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19. Clin Infect Dis. 2022 Jun 23:ciac512. doi: 10.1093/cid/ciac512. Epub ahead of print. PMID: 35737946. *contributed equally
Regan J, Flynn JP, Choudhary MC, Uddin R, Lemieux J, Boucau J, Bhattacharyya RP, Barczak AK, Li JZ, Siedner MJ: Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay. Open Forum Infect Dis 2022, 9(3):ofac022.
2021
Siedner MJ, Boucau J, Gilbert R, Uddin R, Luu J, Haneuse S, Vyas T, Reynolds Z, Iyer S, Chamberlin G, Goldstein RH, North CM, Sacks CA, Regan J, Flynn JP, Choudhary MC, Vyas JM, Barczak AK*, Lemieux J*, Li JZ*. Duration of viral shedding and culture positivity with post-vaccination breakthrough delta variant infections. JCI Insight. 2021 Dec 6;e155483. doi: 10.1172/jci.insight.155483. *contributed equally
Hinman AE, Jani C, Pringle SC, Zhang WR, Jain N, Martinot AJ, Barczak AK. Mycobacterium tuberculosis canonical virulence factors interfere with a late component of the TLR2 response. Elife. 2021 Nov 10;10:e73984. doi: 10.7554/eLife.73984.
Yonker LM, Boucau J, Regan J, Choudhary MC, Burns MD, Young N, Farkas EJ, Davis JP, Moschovis PP, Kinane TB, Fasano A, Neilan AM, Li JZ*, Barczak AK*. Virologic features of SARS-CoV-2 infection in children. J Infect Dis. 2021 Oct 14;jiab509. *contributed equally
North CM*, Barczak AK*, Goldstein RH, Healy B, Finkelstein DM, Ding D, Kim J, Boucau J, Shaw B, Gilbert R, Vyas T, Reynolds Z, Regan J, Flynn J, Choudhary M, Vyas J, Laskowski K, Dighe A, Lemieux J, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA. Determining the Incidence of SARS-CoV-2 among early Recipients of COVID-10 Vaccination [DISCOVER-COVID19]. Clin Infec Dis 2021, Aug 7:ciab643. *contributed equally
Bebell LM, Gonzalez RG, Barczak AK, Anahtar MN. Case 1-2021: A 76-Year-Old Woman with Lethargy and Altered Mental Status. N Engl J Med. 2021 Jan 14; 384(2):166-176
2020
Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020 12 03; 383(23):2291-2293.
Lazarus JE, Branda JA, Gandhi RG, Barshak MB, Zachary KC, Barczak AK. Disseminated Intravascular Infection Caused by Paecilomyces variotii: Case Report and Review of the Literature. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa166.
Oberfeld B, Achanta A, Carpenter K, Chen P, Gilette NM, Langat P, Said JT, Schiff AE, Shou AS, Barczak AK, and Pillai S. Snapshot: COVID-19. Cell, 29 Apr 2020, 181(4):954-954.e1.
2018
Libardo MDJ, de la Fuente-Nunez C, Anand K, Krishnamoorthy G, Kaiser P, Pringle SC, Dietz C, Pierce S, Smith MB, Barczak A, Kaufmann SHE, Singh A, and Angeles-Boza AM. Phagosomal Copper-Promoted Oxidative Attack on Intracellular Mycobacterium tuberculosis. ACS Infect Dis, 2018 Sep 6.
Lu LL, Kwon DS, Barczak AK. Physician-Scientists in the Evolving Landscape of Biomedical Research. J Infect Dis 2018 Aug 14;218(suppl_1):S1-S2.
2017
Barczak AK*, Avraham R*, Singh S, Luo SS, Zhang WR, Bray MA, Thompson M, Nietupski RM, Golas A, Fitzgerald M, Smith RS, White DW, Tischler AD, Carpenter AE, Hung DT. Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence. In revision. *these authors contributed equally